Blood cancers, Chronic leukaemia, Chronic lymphocytic leukaemia (CLL), Leukaemia
Results
Phase 2
This trial was to see if adding rituximab (Mabthera) to fludarabine, cyclophosphamide and mitoxantrone chemotherapy helped to improve treatment outcome for chronic lymphocytic leukaemia.
Recruitment start: 1 July 2005
Recruitment end: 10 January 2007
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Peter Hillmen
Cancer Research UK
Experimental Cancer Medicine Centre (ECMC)
National Institute for Health Research Cancer Research Network (NCRN)
Roche
The Leeds Teaching Hospitals NHS Trust
This is Cancer Research UK trial number CRUKE/04/018.
Last reviewed: 18 June 2012
CRUK internal database number: 545
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
